Streetbeat News

Equity Actions

GES

Analyst ratings for Guess (NYSE:GES) show varied sentiments, with recent evaluations ranging from bullish to bearish. The average 12-month price target is now $25.75, down 8.04% from the previous $28.00. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting their reaction to Guess's performance and market conditions. Guess's financials indicate strong profitability and financial health but a higher level of financial risk due to a debt-to-equity ratio above industry average.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 3:01 pm

DOCS

Doximity (NYSE:DOCS) received mixed analyst ratings in the last quarter, with a shift towards a more cautious stance. The recent ratings show a trend from indifferent to somewhat bearish, with 5 indifferent and 1 somewhat bearish rating. Analysts have updated their 12-month price targets, indicating an average target of $29.00, a high of $32.00, and a low of $25.00, reflecting a 16% increase from the previous average of $25.00. Doximity's financial performance is strong, with significant revenue growth, high net margin, and solid returns on equity and assets, alongside a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 3:01 pm

FTAI

FTAI Aviation (NASDAQ:FTAI) has seen a variety of analyst opinions over the past three months, with recent updates showing a bullish trend. The average 12-month price target has been raised to $69.8, reflecting a 43.18% increase. Analysts from Benchmark, Morgan Stanley, Barclays, and Stifel have raised their price targets, indicating positive sentiment towards FTAI's financial performance and market position. The company has demonstrated strong financial health with a revenue growth rate of 14.02%, a net margin of 35.18%, and an exceptional ROE of 81.63%, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 3:00 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for March 15th, 2024, provides trading strategies for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA based on proprietary formulas. It outlines potential price movements and targets for each asset, emphasizing the importance of monitoring these stocks for breakouts or reversals. The memo also highlights the significance of the day due to the release of Empire Manufacturing data and it being Triple Witching Friday, which could increase market volatility.

Portfolio Pulse from RIPS

March 15, 2024 | 2:46 pm

MRVL

Marvell Tech (NASDAQ:MRVL) has seen significant options trading activity, indicating a split sentiment among big-money investors, with 50% bullish and 50% bearish. The trading volume suggests they expect the stock to move within a $60.0 to $120.0 price range. Recent trades include both puts and calls, with the largest trades showing a mix of bullish and bearish expectations. Marvell Tech, a leading fabless chip designer, has its stock currently priced at $65.73, with analysts giving mixed reviews but generally maintaining positive outlooks with target prices ranging from $84 to $100.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 2:33 pm

SNOW

32 financial analysts have recently evaluated Snowflake (NYSE:SNOW), showing a mix of bullish to bearish sentiments. The average 12-month price target is $221.19, a slight decrease from the previous $227.04. Analyst actions include both upgrades and downgrades, reflecting changing market conditions and company performance. Snowflake's financials reveal a positive revenue trend but challenges in net margin and ROA, with a strong ROE and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 2:00 pm

CYRX

Analyst ratings for CryoPort (NASDAQ:CYRX) show a mix of opinions, with recent actions including ratings adjustments and changes in price targets. The average 12-month price target is now $17.75, up from $17.17. CryoPort faces challenges such as a decline in revenue, below-average net margin, and high debt-to-equity ratio, impacting its financial health. The company operates globally, providing temperature-controlled supply chain solutions to the life sciences industry.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 2:00 pm

VIR

Vir Biotechnology (NASDAQ:VIR) has been analyzed by 5 analysts, showing a mix of bullish and indifferent sentiments. The average 12-month price target is $64.8, up 22.26% from the previous $53.00, with a high estimate of $110.00 and a low of $9.00. Recent analyst actions include maintaining, raising, and lowering ratings and price targets. The company faces revenue challenges with a -55.93% decline over 3 months but has strong net margin and ROE figures, indicating effective cost management and use of equity.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 2:00 pm

APA

APA (NASDAQ:APA) has been the subject of diverse analyst ratings over the last three months, with a shift towards a more bearish outlook in the last 30 days. The average 12-month price target for APA has decreased by 10.21% to $43.7. Analysts from firms like Mizuho, Piper Sandler, and Truist Securities have adjusted their ratings and price targets, reflecting changes in market conditions and APA's performance. Despite facing challenges in revenue growth and debt management, APA maintains strong profitability indicators such as an exceptional net margin of 81.82%, an impressive ROE of 94.99%, and an ROA of 12.32%.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 2:00 pm

STLD

Steel Dynamics (NYSE:STLD) has seen a 19.05% increase in short interest since its last report, with 5.18 million shares sold short, representing 4.0% of its float. This indicates a bearish sentiment among investors, although it's below the peer group average of 4.66%. The article suggests that an increase in short interest doesn't necessarily predict a price drop and can be bullish.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 1:30 pm